Albert Wolkerstorfer
Overview
Explore the profile of Albert Wolkerstorfer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
872
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Buchem-Post N, Ouwerkerk W, Bekkenk M, Wolkerstorfer A, Spuls P, Musters A, et al.
J Dermatol
. 2025 Feb;
PMID: 39950702
During the COVID-19 pandemic, the daily life of many patients with dermatological immune-mediated inflammatory diseases (DIMIDs), such as atopic dermatitis (AD), psoriasis, and vitiligo, was impacted by social restrictions caused...
2.
Speeckaert R, Duponselle J, Wolkerstorfer A, Speeckaert M, van Geel N
J Eur Acad Dermatol Venereol
. 2025 Feb;
PMID: 39902940
No abstract available.
3.
Ezzedine K, Wolkerstorfer A, Wei S, Korba A, Kornacki D, Rosmarin D
J Eur Acad Dermatol Venereol
. 2024 Oct;
PMID: 39417427
No abstract available.
4.
Yin Q, Wolkerstorfer A, Lapid O, Qayumi K, Alam M, Al-Niaimi F, et al.
Am J Clin Dermatol
. 2024 Sep;
25(6):1009-1017.
PMID: 39298112
Background: Intralesional corticosteroid administration (ICA) is a first-line keloid treatment. However, it faces significant variability in current clinical and scientific practice, which hinders comparability of treatment results. Objectives: The aim...
5.
Bekkers V, Barsoum P, Yin Q, Niessen F, van Zuijlen P, Lapid O, et al.
Dermatol Surg
. 2024 Jun;
50(10):913-921.
PMID: 38874219
Background: The efficacy of keloid treatment in randomized studies is highly variable. However, no systematic review has been performed to evaluate the effect of different keloid properties on treatment efficacy....
6.
Yin Q, Bekkers V, Roelofs M, Dobbe J, de Vos J, Bloemen P, et al.
Arch Dermatol Res
. 2024 Jun;
316(7):368.
PMID: 38850361
Intralesional corticosteroid injections are a first-line treatment for keloids; yet clinical treatment results are highly variable and often suboptimal. Variation in triamcinolone acetonide (TAC) biodistribution may be an important reason...
7.
van Geel N, Delbaere L, Mertens L, Vandaele V, Depaepe L, Van Causenbroeck J, et al.
J Clin Med
. 2024 May;
13(9).
PMID: 38731208
There is currently no guidance on how to interpret the global degrees of activity (worsening) and repigmentation (improvement) in vitiligo. Stratification into global degrees can be completed for static evaluations...
8.
van Santen S, van Zuuren E, Wolkerstorfer A, van der Bent S
Dermatol Surg
. 2024 Mar;
50(6):597-598.
PMID: 38477881
No abstract available.
9.
Bekkers V, Van Eijsden C, Yin Q, Wolkerstorfer A, Prens E, van Doorn M
Clin Drug Investig
. 2023 Dec;
44(1):51-57.
PMID: 38093082
Background: Keloids and hypertrophic scars can cause severe pain, pruritus, and psychological distress. Conventional intralesional corticosteroid treatment with needle injections remains challenging, especially in children with needle phobia. Objective: We...
10.
Langbroek G, Stor M, Janssen V, de Haan A, Horbach S, Graupera M, et al.
J Invest Dermatol
. 2023 Nov;
144(6):1378-1388.e1.
PMID: 38013159
Capillary malformations (CM) (port-wine stains) are congenital skin lesions that are characterized by dilated capillaries and postcapillary venules. CMs are caused by altered functioning of the vascular endothelium. Somatic genetic...